Condition

Femoral Neck Fractures

ClinicalTrials.gov condition label

Clinical trials10

Recruiting1

Common interventions10

Lead sponsors shown6

Clinical trials

10 shown

Clinical Outcomes of Primary Cementless Total Hip Arthroplasty Using the Collarless Actis StemNCT07828080 · 2025-06-18

RECRUITING

G7 Freedom Constrained Vivacit-E LinersNCT05587244 · 2023-05-08

ENROLLING_BY_INVITATION

G7 Dual Mobility With Vivacit-E or Longevity PMCFNCT05548972 · 2023-03-20

ENROLLING_BY_INVITATION

Study to Evaluate the Safety and Efficacy of OR3O™ Dual Mobility System vs. Conventional Single Bearing Design Total Hip SystemNCT04941729 · 2022-06-24

TERMINATED

Insignia™ Hip Stem Outcomes StudyNCT05144191 · 2022-02-07

ACTIVE_NOT_RECRUITING

Exception Cementless Hip StemNCT04349046 · 2021-01-01

ACTIVE_NOT_RECRUITING

Squeaking in Ceramic-on-Ceramic Total Hip Arthroplasty Using Delta TT CupNCT04594564 · 2020-10-01

COMPLETED

G7 BiSpherical Acetabular Shell PMCF StudyNCT03266874 · 2017-12-10

ACTIVE_NOT_RECRUITING

Non-Interventional, Multicenter Bicontact® E PMCF StudyNCT03442855 · 2017-02-01

COMPLETED

PMCF Study of the CLS Brevius Stem With Kinectiv TechnologyNCT03410940 · 2011-01-07

TERMINATED

Common interventions

CLS Brevius stem with Kinectiv technologyDEVICE1Collarless Actis femoral stemDEVICE1ConventionalDEVICE1G7 Dual Mobility Longevity bearingDEVICE1G7 Dual Mobility with Vivacit-E bearingDEVICE1Insignia uncemented Hip StemDEVICE1OR3O™ - Dual Mobility SystemDEVICE1Total hip arthoplasty (THA)DEVICE1Total hip arthroplasty with Delta TT cupPROCEDURE1Total Hip Arthroplasty with G7 Freedom Constrained Vivacit-E LinersDEVICE1

Leading sponsors

Zimmer Biomet5Aesculap AG1Seoul National University Bundang Hospital1Seoul National University Hospital1Smith & Nephew Medical (Shanghai) Ltd1Stryker Orthopaedics1

Trial status mix

ACTIVE_NOT_RECRUITING3

COMPLETED2

ENROLLING_BY_INVITATION2

TERMINATED2

RECRUITING1

Phase mix

NA5

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.